Precigen financials
$8.05+3.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $9.7M | $3.9M | $6.2M | $26.9M | $14.3M | $32.0M |
| Gross profit | $4.9M | -$342.0K | $106.0K | $20.6M | $8.5M | $26.6M |
| Gross margin | 50.2% | −8.7% | 1.7% | 76.4% | 59.7% | 83.2% |
| Operating income | -$110.5M | -$135.0M | -$99.8M | -$75.7M | -$91.9M | -$86.3M |
| Net income | -$429.6M | -$126.2M | -$95.9M | $28.3M | -$92.2M | -$170.5M |
| Net margin | −4436.6% | −3216.2% | −1540.6% | 105.2% | −646.0% | −533.0% |
| Diluted EPS | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 |
| EBITDA | -$103.4M | -$90.2M | -$82.3M | -$63.8M | -$77.6M | -$68.0M |
| Operating cash flow | -$87.8M | -$68.2M | -$66.9M | -$65.0M | -$55.8M | -$77.0M |
| Free cash flow | -$89.8M | -$76.8M | -$68.5M | -$70.0M | -$63.0M | -$84.5M |
| Diluted shares | 313.0M | 267.7M | 244.5M | 200.4M | 197.8M | 167.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.2M | $29.5M | $7.6M | $4.9M | $36.4M | $51.8M |
| Short-term investments | $67.6M | $68.4M | $55.3M | $51.1M | $72.2M | $48.3M |
| Total debt | $93.2M | $0.00 | $0.00 | $43.2M | $179.9M | $171.9M |
| Total assets | $155.5M | $145.3M | $151.0M | $216.0M | $359.9M | $314.6M |
| Total liabilities | $134.6M | $78.5M | $32.5M | $89.7M | $252.5M | $247.4M |
| Shareholders' equity | $20.9M | $38.5M | $118.5M | $126.3M | $107.3M | $67.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology